<DOC>
	<DOC>NCT01148147</DOC>
	<brief_summary>Aim of the study is to evaluate the benefits from adjunctive intracoronary administration of adenosin in elective patients undergoing coronary angioplasty.</brief_summary>
	<brief_title>Intracoronary Adenosine Administration to Prevent Periprocedural Myonecrosis in Elective Coronary Angioplasty</brief_title>
	<detailed_description>This study will investigate the effects of adjunctive intracoronary administration of adenosine on periprocedural myocardial infarction as compared to placebo. This is a double-blind randomized trial single-center study. The enrollment will last 10 months.</detailed_description>
	<mesh_term>Adenosine</mesh_term>
	<criteria>Patients undergoing elective coronary angioplasty Marked Bradycardia (&lt; 40 bpm) Previous allergy to adenosine Inability to sign the informed consent Asthma Elevated cardiac enzymes (troponin I o CKMB)</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Adenosine</keyword>
	<keyword>randomized trial</keyword>
	<keyword>periprocedural myocardial necrosis</keyword>
	<keyword>elective coronary angioplasty</keyword>
</DOC>